scispace - formally typeset
Search or ask a question

Showing papers by "Daniel M. Brown published in 2002"


Patent
07 Nov 2002
TL;DR: A pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula (I) or (II) as defined in this paper, in admixture with a physiologically acceptable excipient diluent or carrier.
Abstract: Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula (I) or (II) as herein defined , in admixture with a physiologically acceptable excipient diluent or carrier

5 citations


Patent
30 Jul 2002
TL;DR: A pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as defined, in admixture with a physiologically acceptable excipient diluent or carrier is defined in this article.
Abstract: Disclosed is a pharmaceutical composition comprising a ribonucleoside analogue in accordance with general formula I or II as herein defined, in admixture with a physiologically acceptable excipient diluent or carrier.

2 citations


Patent
07 Nov 2002
TL;DR: In this paper, a composition pharmaceutique comprenant un ribonucleoside analogue de formule generale (I) ou (II), melange a un excipient, a un diluant, ou a support physiologiquement acceptable.
Abstract: L'invention concerne une composition pharmaceutique comprenant un ribonucleoside analogue de formule generale (I) ou (II), melange a un excipient, a un diluant, ou a un support physiologiquement acceptable.